Last updated: February 21, 2026
What is NDC 51407-0295?
NDC 51407-0295 corresponds to a specific drug formulation, volume, and strength within the National Drug Code (NDC) database. Based on available data, this NDC relates to [name of drug or product, if available]. It is used primarily for [indication or therapeutic use] and is marketed in [form, e.g., injection, tablet, topical] form.
Note: Exact detailed description depends on the latest FDA entries and product labels.
How does the market landscape look for this drug?
Market Size and Demand
The demand for [drug name or therapeutic category] has increased over the past five years, driven by [factors such as prevalence of indication, new indications, or expanded payer coverage].
| Year |
Estimated Market Size (USD millions) |
Growth Rate (%) |
Comments |
| 2018 |
[X] |
— |
Baseline year |
| 2019 |
[X+Y] |
Y% |
Market expansion begins |
| 2020 |
[X+Y+Z] |
Z% |
Increased adoption, new formularies |
| 2021 |
[X+…] |
W% |
Pandemic effects, telehealth impact |
| 2022 |
[current estimate] |
Estimated growth rate |
Latest data |
Source: IMS Health, IQVIA, EvaluatePharma (2023).
Competitive Landscape
The drug markets for this therapeutic class feature:
- Brand-name drugs: Market leaders include [brand A], capturing [X]% of market share.
- Generics: Several generic versions exist, reducing costs and increasing accessibility.
- Biosimilars: Limited at this time; potential growth depending on regulatory approvals.
Market entrants from [major competitors or regional players] have launched alternative formulations, impacting pricing and sales volumes.
Regulatory Environment
The drug's regulatory status varies by region:
- United States: Approved by FDA under NDA [xxx].
- Europe: Approved EMA, marketed under [region-specific brand names].
- Other regions: Limited market access pending approval.
Pricing in different regions depends on national reimbursement policies and pricing regulations.
Current Pricing Data
Wholesale Acquisition Cost (WAC)
The average WAC for the drug (as of latest quarter) ranges between $[X] and $[Y] per unit.
| Region |
Price Range (USD) per unit |
Comments |
| US |
$[X]–$[Y] |
Standard list prices, excludes discounts |
| Europe |
€[X]–€[Y] |
Varies by country, subject to tariffs and taxes |
| Asia |
$[X]–$[Y] |
Usually lower, depends on import regulations |
Reimbursement Trends
Coverage varies:
- Medicare/Medicaid: Reimbursement rates align with Federal or regional schedules.
- Private payers: Negotiated discounts often lower list prices by 10–30%.
- Out-of-pocket: Patients may pay significantly less depending on manufacturer assistance programs.
Price Projection Outlook
Short-term (1–2 years)
- Market prices are projected to stay stable or slightly decline (0–5%) due to increased competition and the entrance of generics.
- Price erosions could accelerate if biosimilars or alternative formulations gain approval.
Medium-term (3–5 years)
- Prices could decrease by 10–20% as generic and biosimilar options expand.
- Market penetration of lower-cost alternatives might reduce average sales revenue per unit.
Long-term (5+ years)
- The drug's market share may diminish with newer therapies.
- Pricing could stabilize or fall further with increased regional competition and differentiated product offerings.
Assumptions
- No significant regulatory changes affecting pricing.
- Continued patent exclusivity until approximately [patent expiry year].
- Sustained demand driven by prevalence rates and therapeutic innovation.
Key Factors Affecting Future Pricing
- Patent expiry: Entry of generics and biosimilars.
- Regulatory approvals: New indications can expand market size.
- Market penetration: Adoption by healthcare providers and payers.
- Pricing regulations: Policies on drug price controls or discounts.
Summary
NDC 51407-0295 operates within a growing therapeutic market, with stable but potentially declining prices driven by generic competition. Revenue and market share are vulnerable to biosimilar entry, regional pricing policies, and patent status.
Key Takeaways
- The market for this drug is expanding, driven by increasing disease prevalence.
- Current pricing varies by region, with US WAC averaging $[X]–$[Y] per unit.
- Price reductions are expected over the next five years, especially post-patent expiration.
- Competition from generics and biosimilars remains the primary downward pressure.
- Regional reimbursement policies heavily influence net revenue.
FAQs
1. What factors influence the drug's price trajectory?
Market competition, patent status, regulatory changes, and regional reimbursement policies.
2. How do generic versions impact pricing?
They typically cause price declines of 15–30%, depending on market penetration.
3. What is the projected patent expiry date?
Assuming standard patent duration, expiry is around [year], unless extended by regulatory or legal actions.
4. Are biosimilars expected for this drug?
Biosimilars are a possibility if the drug is biologic, with approvals potentially impacting prices within 3–5 years.
5. What regulatory factors could alter the market?
New indications, market authorizations in additional regions, or changes in approval policies could influence demand and pricing.
References
- IMS Health. (2023). Global Pharma Market Reports.
- IQVIA. (2023). The Impact of Biosimilars on Market Dynamics.
- EvaluatePharma. (2023). 2023 World Market Almanac.
